A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...
NewsNation on MSN
Experimental Alzheimer’s drug could prevent disease early
The experimental drug, NU-9, targets toxic proteins that may trigger Alzheimer’s decades before memory loss begins. In mice, ...
The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...
Music motivates and inspires and is a powerful and nonthreatening medium and therefore, people with Alzheimer’s react ...
A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...
Morning Overview on MSN
A new drug may stop Alzheimer’s before memory loss starts
Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today reported completion of ...
November is Alzheimer’s Awareness Month, a time to heighten awareness about Alzheimer’s disease and show support for the many people and families living with it. First discovered in a 50-year-old ...
HARTFORD, Conn. -- The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving ...
New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback